A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines
NCT05152576
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Forehead Lines
Interventions
DRUG:
OnabotulinumtoxinA X
DRUG:
Placebo
Sponsor
Allergan